Recent studies in mice sought to identify the mechanisms that are critical for TRP53-mediated tumour suppression, using sensitised shRNA gene knock-down and CRISPR/Cas9 knockout screens in cells in culture and even in vivo [5, 6]. Here, TP53 is linked to neoplasm.